0
Abstract: Poster Presentations |

THERAPEUTIC INTERVENTIONS FOR AIRWAY REMODELING IN PATIENTS WITH ASTHMA: EVALUATION WITH HRCT SYSTEMATIC REVIEW WITH METAANALYSIS FREE TO VIEW

Shiman Wu, MD*; J. Mark Fitzgerald, MD
Author and Funding Information

The First Hospital of Shanxi Medical University, Taiyuan, Peoples Rep of China



Chest. 2006;130(4_MeetingAbstracts):161S. doi:10.1378/chest.130.4_MeetingAbstracts.161S-a
Text Size: A A A
Published online

Abstract

PURPOSE: It was recognized that treatments could improve clinical symptoms and lung functions, but it is still controversial whether treatments can reduce the airway wall thickness and change the pulmonary density. The review is to confirm the effects of treatments on the morphological abnormalities of the airway and parenchyma in asthma using HRCT.

METHODS: We systematically searched five databases for relevant studies and abstracted the data. HRCT findings were pooled as the effects of treatment in both random and fixed effects models for RCTs and case-control studies. Heterogeneity was assessed with Chi-squared test, and publication bias was examined with Funnel plots.

RESULTS: Among the seven eligible papers including two RCTs and five case-control studies, six trials used various inhaled corticosteroids for asthmatics (dosage: 200g-1600g/d, duration: 4 weeks-16.8 months), and one trial chose montelukast to treat asthmatics (10mg/d, 4 weeks). There was a significant difference in MLD, BWI, air trapping, and centrilobular prominence between posttreatment and pretreatment in asthmatics. MLD after treatment increased 9.72 (HU),BWI diminished 0.07, air trapping decreased 0.41 scores, centrilobular prominence reduced 0.67 grades, and LAA declined 7.30%. These alterations were consistent with the changes in FEV1, FEV1 %, PEF and PC20. However, the pooled results produced a negative conclusion in WA, WA% and BD. Compared with the controls, the posttreatment asthmatics had still lower MLD, higher BMI, more grades of centrilobular prominence, more prevalent air trapping and greater LAA. These changes of HRCT findings were coincident with the changes in FEV1, FEV1 %, PEF and PC20. Nevertheless, there were no differences of WA, WA% and BD between the posttreatment asthmatics and the controls.

CONCLUSION: Treatments could partly ameliorate the morphological abnormalities of airway and parenchyma in asthmatics, and the alterations were associated with improved lung functions and elevated PC20. However, treatments could not completely make the worse morphological abnormalities in asthmatics normalization.

CLINICAL IMPLICATIONS: This should be stressed that long-term and more studies evaluating airway remodeling by HRCT may confirm whether early treatment prevents airway remodeling in asthmatics.

DISCLOSURE: Shiman Wu, None.

Wednesday, October 25, 2006

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543